Car-T Cell Therapy
CAR-T cell therapy (chimeric antigen receptor T-cell therapy) is an advanced form of immunotherapy that uses a patient’s own immune cells to fight disease. In this approach, T cells are collected from the blood, genetically modified in a lab to recognize specific targets (such as cancer cells), and then infused back into the body. Once returned, these engineered cells can identify and attack harmful cells more effectively. Originally developed for certain cancers, CAR-T therapy is now also being studied for autoimmune diseases, where it may help reset or rebalance the immune system. AiArthritis is committed to keeping up to date on the latest developments of CAR-T cell therapy. Here you will discover all published information we have about CAR-T.
Read about CAR-T Cell Therapy on Our Blog
This is paragraph text. Click it or hit the Manage Text button to change the font, color, size, format, and more. To set up site-wide paragraph and title styles, go to Site Theme.
Videos on CAR-T Cell Therapy
This is paragraph text. Click it or hit the Manage Text button to change the font, color, size, format, and more. To set up site-wide paragraph and title styles, go to Site Theme.
Episode 113: What is CAR-T Therapy?
CAR-T Therapy is one of the most talked about advances in autoimmune research today, offering new hope for people living with AiArthritis diseases such as lupus, myositis, scleroderma, and Sjögren’s. In this episode, co-hosts Leila P.L. Valete, AiArthritis Health Education Manager, and Tiffany Westrich-Robertson, CEO and Original Founder of AiArthritis, explain what CAR-T is, how it works, and why it matters.
Go With Us! to ACR 2025: CAR T Cell Therapy Breakthroughs in Autoimmune Disease
In this update, Tiffany breaks down the latest research on CAR T cell therapy — a groundbreaking treatment that reprograms your own immune cells to “reset” the system and stop autoimmune attacks.
Go With Us! to ACR 2025: IgG4-RD and CAR T Therapy: Science Bringing New Hope for Patients
Join Leila P.L. Valete, Health Education Manager at AiArthritis, as she breaks down key updates from Day 1 of ACR 2025 through the Go With Us! program.
Go With Us! to EULAR 2025: Could CAR-T Lead to Drug-Free Remission for Autoimmune Diseases?
In this Go With Us! video from EULAR 2025, Leila—AiArthritis’ Health Education Manager—dives into one of the most exciting sessions of the conference: CAR-T cell therapy and its potential to reset the immune system in autoimmune diseases like lupus and systemic sclerosis.
Revolutionary Cell Therapies for Autoimmune Diseases: ACR 2024 Highlights with Tiffany
Tiffany Westrich Robertson, CEO of AiArthritis and an axial spondyloarthritis patient, shares groundbreaking updates from ACR 2024 on cell therapy breakthroughs for autoimmune diseases like lupus, myositis, and systemic sclerosis.
Revolutionary Advances in Rheumatology: CAR-T and Precision Medicine Insight from Tiffany
In this update from EULAR 2024, we explore groundbreaking advancements in precision medicine and their potential to transform rheumatology. Learn about the science behind precision medicine, its potential to expedite diagnosis and personalize treatment, and the exciting prospects for achieving remission.
Thank you to our sponsors
